1. Home
  2. RDY vs RNW Comparison

RDY vs RNW Comparison

Compare RDY & RNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
    SELLHOLDBUYas of 6 hours ago
  • RNW
    SELLHOLDBUYas of 6 hours ago
  • Stock Information
  • Founded
  • RDY 1984
  • RNW 2011
  • Country
  • RDY India
  • RNW United Kingdom
  • Employees
  • RDY N/A
  • RNW N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • RNW Electric Utilities: Central
  • Sector
  • RDY Health Care
  • RNW Utilities
  • Exchange
  • RDY Nasdaq
  • RNW Nasdaq
  • Market Cap
  • RDY 2.1B
  • RNW 2.2B
  • IPO Year
  • RDY N/A
  • RNW N/A
  • Fundamental
  • Price
  • RDY $13.24
  • RNW $6.07
  • Analyst Decision
  • RDY Buy
  • RNW Strong Buy
  • Analyst Count
  • RDY 1
  • RNW 1
  • Target Price
  • RDY $17.00
  • RNW $7.50
  • AVG Volume (30 Days)
  • RDY 1.9M
  • RNW 778.0K
  • Earning Date
  • RDY 05-06-2025
  • RNW 02-18-2025
  • Dividend Yield
  • RDY 3.61%
  • RNW N/A
  • EPS Growth
  • RDY 2.68
  • RNW N/A
  • EPS
  • RDY 0.75
  • RNW 0.04
  • Revenue
  • RDY $3,637,607,642.00
  • RNW $1,006,524,942.00
  • Revenue This Year
  • RDY $17.23
  • RNW N/A
  • Revenue Next Year
  • RDY $9.19
  • RNW $38.75
  • P/E Ratio
  • RDY $17.94
  • RNW $156.00
  • Revenue Growth
  • RDY 14.74
  • RNW N/A
  • 52 Week Low
  • RDY $12.50
  • RNW $5.15
  • 52 Week High
  • RDY $16.89
  • RNW $7.49
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • RNW 45.92
  • Support Level
  • RDY $13.09
  • RNW $5.76
  • Resistance Level
  • RDY $13.85
  • RNW $6.29
  • Average True Range (ATR)
  • RDY 0.14
  • RNW 0.15
  • MACD
  • RDY 0.02
  • RNW -0.00
  • Stochastic Oscillator
  • RDY 19.74
  • RNW 58.10

Stock Price Comparison Chart: RDY vs RNW

RDY
RNW
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April01020304050607080RDY VS RNW

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use